NurExone Biologic Inc.
NRXBF
$0.50
-$0.0122-2.38%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.04M | -4.23M | -4.14M | -3.86M | -3.64M |
| Total Depreciation and Amortization | 85.00K | 49.00K | 49.00K | 42.00K | 33.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 993.00K | 860.00K | 655.00K | 711.00K | 661.00K |
| Change in Net Operating Assets | -923.00K | -461.00K | -320.00K | -480.00K | 4.00K |
| Cash from Operations | -4.89M | -3.79M | -3.76M | -3.58M | -2.94M |
| Capital Expenditure | -649.00K | -670.00K | -368.00K | -309.00K | -120.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.00K | 13.00K | 13.00K | 23.00K | 23.00K |
| Cash from Investing | -658.00K | -657.00K | -355.00K | -286.00K | -97.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -30.00K | -31.00K | -34.00K | -28.00K | -28.00K |
| Issuance of Common Stock | 5.84M | 4.71M | 4.57M | 4.55M | 1.07M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 71.00K | 1.12M | 1.05M | 1.02M | 95.00K |
| Cash from Financing | 5.88M | 5.79M | 5.58M | 5.54M | 1.13M |
| Foreign Exchange rate Adjustments | -173.00K | 32.00K | 34.00K | -2.00K | -16.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 159.00K | 1.38M | 1.51M | 1.67M | -1.92M |